Related Articles
Selective leukemia cell death by activation of the double-stranded RNA-dependent protein kinase PKR
Synergistic growth inhibitory effects of interferon-α and lovastatin on bcr-abl positive leukemic cells
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway
Nilotinib rapidly reverses breakpoint cluster region-Abelson oncogene fusion gene and M244V mutations in a patient with chronic myelogenous leukemia: A case report